Cyclophosphamide, hexamethylmelamine, adriamycin and cisplatin combination chemotherapy in mixed mesodermal sarcoma of the female genital tract.

[1]  T. Wahlström,et al.  Sarcomas of the uterus: A clinicopathologic study of 119 patients , 1986, Obstetrics and gynecology.

[2]  G. Sutton,et al.  Adriamycin Chemotherapy for Malignant Mixed Mesodermal Tumor of the Ovary A Gynecologic Oncology Group Study , 1986, American journal of clinical oncology.

[3]  P. Disaia,et al.  Phase II trial of cisplatin in the treatment of patients with advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group Study. , 1986, Cancer treatment reports.

[4]  C. Crum,et al.  Uterine sarcomas: a clinicopathologic study, 1965-1981. , 1984, Gynecologic oncology.

[5]  G. Fletcher,et al.  Malignant mixed müllerian tumors of the uterus , 1984, Cancer.

[6]  R. Zaino,et al.  A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas , 1983, Cancer.

[7]  R. Freedman,et al.  Treatment of advanced uterine sarcoma with adriamycin. , 1983, Gynecologic oncology.

[8]  M. Piver,et al.  Cyclophosphamide, vincristine, adriamycin, and dimethyl-triazeno imidazole carboxamide (CYVADIC) for sarcomas of the female genital tract. , 1982, Gynecologic oncology.

[9]  P. Sordillo,et al.  Phase II trial of cisplatin (CPDD) in previously treated patients with advanced soft tissue sarcoma , 1982, Cancer.

[10]  R. Sylvester,et al.  E.O.R.T.C. phase II study of cisplatin in cyvadic-resistant soft tissue sarcoma. , 1979, European journal of cancer.

[11]  L. Peters,et al.  Patterns of recurrence in malignant mixed müllerian tumor of the uterus , 1986, Cancer.